Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II interferon gamma-1b trial in Friedreich's ataxia
2012-001881-14Phase 2Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Jan 2013
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon gamma-1b in Friedreich ataxia (FA), sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Primary endpoint: Increase of cellular frataxin after treatment. Started Jan 2013; status: active.
02
Drugs
interferon gamma-1b
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on 2012-001881-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001881-14.